Hologic Inc. develops, manufactures, and supplies diagnostics, medical imaging systems and surgical products which cater to the healthcare needs of women. Hologic operates through the following four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health.
| Revenue (Most Recent Fiscal Year) | $4.10B |
| Net Income (Most Recent Fiscal Year) | $565.70M |
| PE Ratio (Current Year Earnings Estimate) | 16.65 |
| PE Ratio (Trailing 12 Months) | 17.56 |
| PEG Ratio (Long Term Growth Estimate) | 2.13 |
| Price to Sales Ratio (Trailing 12 Months) | 4.08 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.30 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 13.13 |
| Pre-Tax Margin (Trailing 12 Months) | 16.61% |
| Net Margin (Trailing 12 Months) | 13.80% |
| Return on Equity (Trailing 12 Months) | 20.13% |
| Return on Assets (Trailing 12 Months) | 11.06% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.75 |
| Quick Ratio (Most Recent Fiscal Quarter) | 3.06 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.50 |
| Inventory Turnover (Trailing 12 Months) | 2.82 |
| Book Value per Share (Most Recent Fiscal Quarter) | $22.69 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.13 |
| Earnings per Share (Most Recent Fiscal Year) | $4.26 |
| Diluted Earnings per Share (Trailing 12 Months) | $2.48 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Common Shares Outstanding | 222.90M |
| Free Float | 218.71M |
| Market Capitalization | $16.72B |
| Average Volume (Last 20 Days) | 2.69M |
| Beta (Past 60 Months) | 0.70 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.88% |
| Percentage Held By Institutions (Latest 13F Reports) | 94.73% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |